Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Mon Compte
Sélection
No element in selection
Favoris
Sélection
Établissements de santé
Contact
Abonnez-vous aux actualités
31 results
Topics : Economics and public health
Topics : Screening, prevention
OK
Chercher
Filter
Topic
Economics and public health
(31)
Plus ...
Screening, prevention
(31)
Health economics
(8)
Organisation of care
(4)
Methodology
(1)
Diseases and conditions
(30)
Plus ...
Infectious diseases
(13)
Plus ...
Virus diseases
(10)
Sexually transmitted diseases
(4)
(3)
Bacterial infections
(2)
Infectious diseases - miscellaneous
(1)
Digestive system diseases
(6)
Plus ...
Liver diseases
(4)
Digestive system cancers
(2)
Nervous system diseases
(5)
Plus ...
Central nervous system diseases
(2)
Nervous system cancers
(2)
Nervous system diseases - miscellaneous
(1)
Neurodegenerative diseases
(1)
Musculoskeletal diseases
(5)
Plus ...
Bone and cartilage diseases
(2)
Musculoskeletal diseases - miscellaneous
(1)
Muscular diseases
(1)
Muscle cancers
(1)
Congenital, genetic and rare diseases
(4)
Endocrine system and metabolic diseases
(4)
Plus ...
Diabetes mellitus
(2)
Metabolic diseases
(1)
Endocrine gland cancers
(1)
Genital diseases
(4)
Plus ...
Genital cancers
(3)
Female genital diseases
(2)
Male genital diseases
(1)
Mental disorders and behavioural conditions
(3)
Plus ...
Disorders of psychological development
(2)
Mental disorders and behavioural conditions - miscellaneous
(1)
Eye diseases
(3)
Plus ...
Eye cancers
(1)
Breast diseases
(3)
Plus ...
Breast cancers
(3)
Pregnancy and reproduction
(3)
Plus ...
Pregnancy
(3)
Respiratory tract diseases
(2)
Plus ...
Respiration disorders
(1)
Respiratory tract cancers
(1)
Skin and connective tissue diseases
(2)
Plus ...
Skin and connective tissue cancers
(1)
Cancers - miscellaneous
(2)
Vascular diseases
(2)
Plus ...
Vascular diseases - miscellaneous
(1)
Peripheral vascular diseases
(1)
Urologic diseases
(1)
Plus ...
Urologic cancers
(1)
Otorhinolaryngologic diseases
(1)
Plus ...
Otorhinolaryngologic cancers
(1)
Blood and lymphatic diseases
(1)
Plus ...
Hematologic cancers
(1)
Heart diseases
(1)
Plus ...
Heart diseases - miscellaneous
(1)
Immune system diseases
(1)
Plus ...
Immunologic deficiency syndromes
(1)
Population groups
(10)
Plus ...
Paediatrics
(9)
Geriatrics
(1)
Diagnostic and therapeutic techniques
(9)
Plus ...
Diagnostic techniques and procedures
(8)
Plus ...
Biology (laboratory tests)
(7)
Medical imaging
(1)
Cell and tissue pathology
(1)
Vaccine
(1)
Drug therapy
(1)
Quality of care and patient safety
(1)
Plus ...
Patient information, patients’ rights, patients’ records
(1)
Plus ...
Patient information and patients’ rights
(1)
Content type
Practice Guidelines and Other Guides
(23)
Plus ...
Public Health guideline
(12)
Practice guidelines
(10)
Methodology guide
(1)
Drugs, devices and medical acts
(7)
Plus ...
Health technology assessment
(6)
Medicine
(1)
Articles and news
(1)
Plus ...
Press release
(1)
Date
Last five years
(8)
Manufacturer
alter
(1)
bioethic
(1)
inconnu
(14)
industriels
(9)
Language
Français
(31)
Active substance
acide clavulanique
(1)
acide folinique
(1)
acide folique
(2)
acide nalidixique
(1)
alanine
(4)
alcool
(13)
aluminium
(1)
amoxicilline
(1)
argent
(4)
arginine
(1)
atropine
(1)
benzoate de sodium
(1)
biotine
(1)
brimonidine
(1)
brinzolamide
(1)
carboplatine
(1)
ceftizoxime
(1)
ceftriaxone
(1)
chlorure de benzalkonium
(1)
chlorure de sodium
(1)
clindamycine
(1)
cuivre
(1)
cystine
(1)
fer
(2)
fer ferreux
(1)
fluorouracil
(1)
fluorouracile
(1)
fluorure de sodium
(1)
gadobutrol
(1)
gadodiamide
(1)
gadolinium
(1)
ganciclovir
(1)
gentamicine
(1)
glucose anhydre
(1)
glutamine
(1)
glycine
(1)
huile de soja
(1)
hydrocortisone
(1)
hydroxyproline
(1)
iobitridol
(1)
iode
(2)
iodixanol
(1)
iohexol
(1)
iopamidol
(1)
iopromide
(1)
ioversol
(1)
isoleucine
(1)
lamivudine
(1)
latanoprost
(1)
leucine
(1)
lithium
(1)
losartan
(1)
lysine
(1)
mezlocilline
(1)
nitisinone
(1)
or colloidal
(1)
ornithine
(1)
oxaliplatine
(1)
phosphate
(1)
pilocarpine
(1)
prednisolone
(1)
pyridoxine
(1)
raltitrexed
(1)
ramipril
(1)
riboflavine
(1)
sodium
(2)
spectinomycine
(1)
sulbactam
(1)
thymidine
(1)
trastuzumab
(1)
trypsine
(1)
tryptophane
(1)
tyrosine
(1)
uracile
(1)
uridine
(1)
valaciclovir
(1)
valine
(1)
valproate de sodium
(1)
zidovudine
(1)
More filter
Save your search
Search Export
Practice guidelines and other guides
- 23 results
Newborn screening for spinal muscular atrophy_Advance assessment of extension of screening to the general population in France
Public Health guideline
- Posted on 10/7/2024
Download
abstract
Add to
my selection
Neurodevelopmental disorders Detection and referral of at-risk children
Practice guidelines
- Posted on 17/3/2020 - Mis à jour le 19/3/2020
Download
abstract
Add to
my selection
Memo : Prevention of positional skull deformities and sudden infant death syndrome
Practice guidelines
- Posted on 5/3/2020
Download
abstract
Add to
my selection
Inborn errors of metabolism : assessment of expanded newborn screening using tandem mass spectrometry in France (part 2)
Public Health guideline
- Posted on 3/2/2020
Download
abstract
Add to
my selection
Evaluation of human papillomavirus (HPV) tests for primary screening of precancerous and cancerous lesions of the cervix and the role of p16/Ki67 dual immunostaining
Public Health guideline
- Posted on 11/7/2019
Download
abstract
Add to
my selection
Child abuse: identification and action to be taken
Practice guidelines
- Posted on 29/9/2017
Download
abstract
Add to
my selection
Place of Point-of-Care Tests (POCTs) in hepatitis B screening strategy
Public Health guideline
- Posted on 6/7/2016
Download
abstract
Add to
my selection
Developmental dysplasia of the hip: screening
Practice guidelines
- Posted on 8/11/2013
Download
abstract
Add to
my selection
Methods for assessing global cardiovascular risk (CVR): use of risk models
Public Health guideline
- Posted on 1/9/2004 - Mis à jour le 27/2/2013
Download
abstract
Add to
my selection
Assessment of screening for cytomegalovirus (CMV) infection in pregnant women in France
Public Health guideline
- Posted on 1/9/2004 - Mis à jour le 19/12/2011
Download
abstract
Add to
my selection
See 23 result in Practice Guidelines and Other Guides
Drugs, devices and medical acts
- 7 results
Usefulness of contrast-enhanced mammography in breast cancer diagnosis strategy - INAHTA Brief
Health technology assessment
- Posted on 22/11/2021 - Mis à jour le 22/11/2021
Download
document
Add to
my selection
Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies
Health technology assessment
- Posted on 19/10/2020
Add to
my selection
Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies
Health technology assessment
- Posted on 16/4/2020 - Mis à jour le 18/5/2020
Download
document
Add to
my selection
Assessment of tissue or cell sample preparation, qualification and selection procedures for cancer somatic gene testing - INAHTA Brief
Health technology assessment
- Posted on 27/12/2019 - Mis à jour le 27/12/2019
Download
document
Add to
my selection
OPTAFLU (Antigènes de surface du virus de la grippe, inactivés, des souches sui...)
Medicine
- Posted on 27/1/2014 - Mis à jour le 12/6/2019
Add to
my selection
Screening for dihydropyrimidine dehydrogenase deficiency to decrease the risk of severe toxicities related to fluoropyrimidines (5-fluorouracil or capecitabine) - INAHTA Brief
Health technology assessment
- Posted on 29/9/2023
Download
document
Add to
my selection
Assessment of chiropodist-podiatrist consultations for preventing foot lesions in diabetic patients with a grade 1 podiatric risk - INAHTA Brief
Health technology assessment
- Posted on 20/12/2018
Download
document
Add to
my selection
See 7 result in Drugs, devices and medical acts
Articles and news
- 1 result
COVID-19: the HAS defines criteria to assess the reliability of serological tests
Press release
- Posted on 16/4/2020 - Mis à jour le 16/4/2020
Add to
my selection
Français
English
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
NU1wKHNZE4f27NDc
